IP Library › Granted Patent US 6,900,046
Granted Patent B2
US 6,900,046 · App. 10/231,354 · Granted May 31, 2005

Human ATPase proteins and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,046
App. No.
10/231,354
Granted
May 31, 2005
Kind
B2
Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims (6)

1. A recombinant expression vector comprising the nucleic acid sequence described in SEQ ID NO: 13.

2. The recombinant expression vector of claim 1 , wherein said vector comprises a nucleic acid sequence that encodes the amino acid sequence of SEQ ID NO 14.

3. A host cell comprising the vector of claim 1 .

4. A gene delivery system comprising an isolated nucleic acid molecule comprising the nucleic acid sequence described in SEQ ID NO:13.

5. The gene delivery system of claim 4 , wherein said isolated nucleic acid molecule is present in a viral vector.

6. The gene delivery system of claim 4 , wherein said isolated nucleic acid molecule is present in a cationic lipid complex.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →